INS and diabetes mellitus: Treated with infliximab and recovered from COVID-19, discharged after 10 days, required insulin but dose has been lowered to 1.1 unit/kg/day plus metformin. Type of diabetes remains unknown, family history of T2DM. Patient is Hispanic.